WINT

WINDTREE THERAPEUTICS INC /DE/

OTC · Biological Products, (No Diagnostic Substances) · Inc. DE · CIK 0000946486
$0.0200 +100.00%
Vol
Inst. Holders2 funds
Inst. Value$64.00
Inst. Activity0 buys / 1 sells
Exchange OTC·Sector Biological Products, (No Diagnostic Substances)·Inc. DE·CIK 0000946486·Prev Close $0.010000

Recent Activity

Inst.
UBS Group AG — NEAR_EXIT
22 shares ($11.00)
Jun 1, 2026 earnings_calendar
WINT Q1 2026 Earnings Scheduled — 2026-06-01

Analyst Ratings

Historical distribution0% buy · 6 analysts · last covering-analyst action Dec 2024
0Strong Buy
0Buy
3Hold
1Sell
2Strong Sell
Historical Analyst Actions
DateFirmActionRating
Dec 4, 2024 HC Wainwright & Co. REITERATE Neutral → Neutral
Jan 3, 2024 HC Wainwright & Co. INITIATE Neutral

Top Institutional Holders

FundValueMove
BANK OF AMERICA CORP$53.00
UBS Group AG$11.00NEAR_EXIT
2 institutional holders with $64.00 total value (125 shares) as of 2025-Q2. Top holders: BANK, UBS. Net selling activity: 1 institutions trimmed/exited vs 0 added.

Top Institutional Holders — 2025-Q2

#FundSharesValue% of TrackedLast Move
1BANK OF AMERICA CORP /DE/103$53.0082.8%
2UBS Group AG22$11.0017.2%NEAR_EXIT -99.9%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
UBS Group AGNEAR_EXIT28,76522-99.9%$11.002025-Q2

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Dec 2024): 0% buy across 6 analysts — 0 strong buy, 0 buy, 3 hold, 1 sell, 2 strong sell. No current recommendation available.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2025-03-31
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
2025-12-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Dec 4, 2024 HC Wainwright & Co. REITERATE Neutral Neutral
Jan 3, 2024 HC Wainwright & Co. INITIATE Neutral

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Apr 1, 2025003120%
Mar 1, 2025003120%
Feb 1, 2025003120%
Jan 1, 2025003120%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Jun 1, 2026
earnings_calendar
WINT Q1 2026 Earnings Scheduled — 2026-06-01
May 27, 2026
earnings_calendar
WINT Q4 2025 Earnings After Market Close — 2026-05-27
Apr 27, 2026
earnings_calendar
WINT Q4 2025 Earnings After Market Close — 2026-04-27
Apr 23, 2026
earnings_calendar
WINT Q4 2025 Earnings After Market Close — 2026-04-23
Apr 15, 2026
earnings_calendar
WINT Q4 2025 Earnings After Market Close — 2026-04-15
Apr 13, 2026
earnings_calendar
WINT Q4 2025 Earnings After Market Close — 2026-04-13